1. Home
  2. LRN vs CRNX Comparison

LRN vs CRNX Comparison

Compare LRN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$85.15

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.73

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRN
CRNX
Founded
2000
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
LRN
CRNX
Price
$85.15
$33.73
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$106.75
$74.78
AVG Volume (30 Days)
685.6K
1.0M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.87
N/A
EPS
3.49
N/A
Revenue
$917,734,000.00
$1,039,000.00
Revenue This Year
$6.18
$722.66
Revenue Next Year
$4.74
$183.79
P/E Ratio
$25.18
N/A
Revenue Growth
3.29
N/A
52 Week Low
$60.61
$24.10
52 Week High
$171.17
$57.99

Technical Indicators

Market Signals
Indicator
LRN
CRNX
Relative Strength Index (RSI) 50.28 29.20
Support Level $80.62 $33.23
Resistance Level $89.29 $37.23
Average True Range (ATR) 2.69 1.62
MACD -0.14 0.13
Stochastic Oscillator 48.57 8.33

Price Performance

Historical Comparison
LRN
CRNX

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: